Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | UNK | — |
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | UNK | — |
had the first shingles shot, but got the shingles/second time all over my head, near my eye; patient received 3 doses of shingles vaccine; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 3rd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, not applicable after receiving Shingles vaccine and an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: had the first shingles shot, but got the shingles/second time all over my head, near my eye) and extra dose administered (Verbatim: patient received 3 doses of shingles vaccine). The outcome of the shingles was not reported and the outcome of the extra dose administered was not applicable. It was unknown if the reporter considered the shingles to be related to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK receipt date: 03-APR-2025 This case was reported by a patient via interactive digital media. Patient had the first shingles shot, but got the shingles, later the doctor said the first shot was no good. Patient got the shingles second time all over head, near eye. They were very, very painful. Patient then got next two shots, that were suppose to be good ones, thank goodness. Patient had 3 doses of shingles vaccine which led to extra dose administered. The follow-up could not be possible as no contact details were available.